» Authors » Francesca Scrimieri

Francesca Scrimieri

Explore the profile of Francesca Scrimieri including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 12
Citations 1432
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Scrimieri F, Bastian E, Smith M, Rehm C, Morse C, Kuruppu J, et al.
J Infect Dis . 2024 Jan; 229(6):1786-1790. PMID: 38226493
A subset of antiretroviral therapy-treated persons with human immunodeficiency virus (HIV), referred to as immunological nonresponders (INRs), fails to normalize CD4+ T-cell numbers. In a case-control study involving 26 INRs...
2.
Singh K, Natarajan V, Dewar R, Rupert A, Badralmaa Y, Zhai T, et al.
AIDS . 2023 Aug; 37(14):2119-2130. PMID: 37555786
Objectives: People with HIV-1 (PWH) on effective antiretroviral therapy (ART) continue to exhibit chronic systemic inflammation, immune activation, and persistent elevations in markers of HIV-1 infection [including HIV-DNA, cell-associated HIV-RNA...
3.
Imamichi H, Smith M, Adelsberger J, Izumi T, Scrimieri F, Sherman B, et al.
Proc Natl Acad Sci U S A . 2020 Feb; 117(7):3704-3710. PMID: 32029589
HIV-1 proviruses persist in the CD4 T cells of HIV-infected individuals despite years of combination antiretroviral therapy (cART) with suppression of HIV-1 RNA levels <40 copies/mL. Greater than 95% of...
4.
Mavilio A, Scrimieri F, Errico D
Biomed Res Int . 2015 Jul; 2015:571314. PMID: 26167489
Objective: To evaluate variability of steady-state pattern electroretinogram (SS-PERG) signal in normal, suspected, and glaucomatous eyes. Methods: Twenty-one subjects with suspected glaucoma due to disc abnormalities (GS), 37 patients with...
5.
Scrimieri F, Askew D, Corn D, Eid S, Bobanga I, Bjelac J, et al.
Oncoimmunology . 2014 Feb; 2(11):e26889. PMID: 24482753
The preclinical development of anticancer drugs including immunotherapeutics and targeted agents relies on the ability to detect minimal residual tumor burden as a measure of therapeutic efficacy. Real-time quantitative (qPCR)...
6.
Patel K, Scrimieri F, Ghosh S, Zhong J, Kim M, Ren Y, et al.
Am J Pathol . 2013 May; 183(1):296-303. PMID: 23665203
Like the p16, SMAD4, and RB1 genes, FAM190A (alias CCSER1) lies at a consensus site of homogeneous genomic deletions in human cancer. FAM190A transcripts in 40% of cancers also contain...
7.
Errico D, Scrimieri F, Riccardi R, Fedeli R, Iarossi G
Clin Ophthalmol . 2011 Dec; 5:1679-86. PMID: 22205828
Purpose: To evaluate the efficacy and the safety of a surgical technique in which classic trabeculectomy ab externo is performed with a double application of low-dose mitomycin C (MMC) in...
8.
Dal Molin M, Hong S, Hebbar S, Sharma R, Scrimieri F, de Wilde R, et al.
Hum Pathol . 2011 Sep; 43(4):585-91. PMID: 21940037
A better molecular characterization of intraductal papillary mucinous neoplasm (IPMN), the most frequent cystic precursor lesion of pancreatic adenocarcinoma, may have a pivotal role in its early detection and in...
9.
DeNicola G, Karreth F, Humpton T, Gopinathan A, Wei C, Frese K, et al.
Nature . 2011 Jul; 475(7354):106-9. PMID: 21734707
Reactive oxygen species (ROS) are mutagenic and may thereby promote cancer. Normally, ROS levels are tightly controlled by an inducible antioxidant program that responds to cellular stressors and is predominantly...
10.
Scrimieri F, Calhoun E, Patel K, Gupta R, Huso D, Hruban R, et al.
Oncotarget . 2011 Mar; 2(1-2):69-75. PMID: 21378412
We found FAM190A transcripts to have internal rearrangements in 40% (19/48) of unselected human cancers. Most of these tumors (84%) had in-frame structures, 94% of which involved deletion of exon...